Indications: Nerlynx® (neratinib) tablets, for oral use, is a kinase inhibitor indicated:
Lorem ipsum, dolor sit amet consectetur adipisicing elit. Repellendus asperiores dolor, voluptatibus aut molestias, dolorem minus exercitationem reiciendis fugit odit atque aperiam nam ipsam eveniet natus, commodi minima obcaecati corporis.
This area doesn't have internal padding.Also, lorem ipsum dolor sit amet consectetur adipisicing elit. Corporis tempora quas nostrum beatae rem debitis eligendi provident maxime esse exercitationem, placeat quod cum sapiente odio, quos explicabo dolore rerum et? Lorem ipsum dolor, sit amet consectetur adipisicing elit. Cupiditate architecto assumenda adipisci! Nobis dicta est recusandae! Eaque provident ipsa sapiente, quisquam iste at magni explicabo quae et consequuntur maiores sequi?
Contraindications: None
Warnings and Precautions:
Adverse Reactions: The most common adverse reactions (reported in ≥5% of patients) were:
To report suspected adverse reactions, contact Puma Biotechnology, Inc. at 1-844-Nerlynx (1-844-637-5969) or FDA at 1-800-332-1088 or www.fda.gov/medwatch.
Drug Interactions:
Use In Specific Populations:
Please see Full Prescribing Information.
Indications: Nerlynx® (neratinib) tablets, for oral use, is a kinase inhibitor indicated: